Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China · Delayed Price · Currency is CNY 5.08
+0.06 (1.20%)
Apr 29, 2026, 3:04 PM CST
SHE:002424 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -99.1 | -103.12 | 33.62 | -414.51 | 138.47 | 118.48 |
Depreciation & Amortization | 124.28 | 124.28 | 115.44 | 116.66 | 116.16 | 107.01 |
Other Amortization | 7.58 | 7.58 | 9.52 | 7.58 | 7.32 | 6.77 |
Loss (Gain) From Sale of Assets | -18.12 | -18.12 | 0.14 | -1.14 | 0.3 | 0.47 |
Asset Writedown & Restructuring Costs | 62.8 | 62.8 | 23.22 | 126.85 | -0.9 | 0.92 |
Loss (Gain) From Sale of Investments | 27.91 | 27.91 | 34.69 | 9.82 | -38.73 | -58.53 |
Provision & Write-off of Bad Debts | - | - | - | - | 60.47 | 66.48 |
Other Operating Activities | -80.43 | 76.36 | 88.98 | 88.9 | 138.73 | 104.78 |
Change in Accounts Receivable | 382.7 | 382.7 | 477.34 | -34.97 | -182.7 | 193.73 |
Change in Inventory | 391.78 | 391.78 | -4.2 | -396.58 | 8.74 | -70.21 |
Change in Accounts Payable | -249.28 | -249.28 | -746.94 | 734.65 | 220.91 | -95.77 |
Change in Other Net Operating Assets | - | - | - | - | 46.12 | -46.12 |
Operating Cash Flow | 595.95 | 748.72 | 9.02 | 125.77 | 502.15 | 324.92 |
Operating Cash Flow Growth | 62.69% | 8200.08% | -92.83% | -74.95% | 54.55% | -40.32% |
Capital Expenditures | -126.22 | -125.24 | -42.02 | -104.12 | -68.45 | -425.73 |
Sale of Property, Plant & Equipment | 23.72 | 23.89 | 0.06 | 1.46 | 0.78 | 0.12 |
Cash Acquisitions | - | - | - | -3.92 | - | - |
Investment in Securities | -0.95 | -4.74 | 133.8 | 63.32 | 80.75 | -162.07 |
Other Investing Activities | 15.06 | 11.32 | -11.32 | 8.43 | 7.33 | 282.47 |
Investing Cash Flow | -88.39 | -94.78 | 80.52 | -34.83 | 20.44 | 42.59 |
Short-Term Debt Issued | - | - | - | - | - | 1,546 |
Long-Term Debt Issued | - | 1,166 | 1,627 | 1,698 | 1,480 | 90 |
Total Debt Issued | 985.13 | 1,166 | 1,627 | 1,698 | 1,480 | 1,636 |
Long-Term Debt Repaid | - | -1,722 | -1,595 | -1,733 | -1,710 | -2,202 |
Total Debt Repaid | -1,604 | -1,722 | -1,595 | -1,733 | -1,710 | -2,202 |
Net Debt Issued (Repaid) | -618.98 | -556.63 | 31.89 | -34.69 | -229.73 | -566.01 |
Repurchase of Common Stock | - | - | -119.58 | -100.01 | - | -100.2 |
Common Dividends Paid | -57.74 | -62.48 | -81.35 | -80.54 | -86.55 | -100.18 |
Other Financing Activities | -17.33 | -17.33 | - | 0.43 | 1 | - |
Financing Cash Flow | -694.05 | -636.44 | -169.04 | -214.81 | -315.28 | -766.39 |
Foreign Exchange Rate Adjustments | 0 | 0 | 0 | -0 | 0 | -0 |
Net Cash Flow | -186.5 | 17.5 | -79.5 | -123.87 | 207.31 | -398.89 |
Free Cash Flow | 469.73 | 623.47 | -33 | 21.65 | 433.7 | -100.81 |
Free Cash Flow Growth | 43.43% | - | - | -95.01% | - | - |
Free Cash Flow Margin | 16.02% | 20.45% | -0.86% | 0.51% | 12.25% | -3.24% |
Free Cash Flow Per Share | 0.35 | 0.48 | -0.02 | 0.02 | 0.31 | -0.07 |
Cash Income Tax Paid | 330.79 | 325.49 | 398.79 | 455.21 | 370.44 | 311.21 |
Levered Free Cash Flow | 530.77 | 675.66 | 106.62 | 412.39 | 464.92 | 245.79 |
Unlevered Free Cash Flow | 530.77 | 675.66 | 160.27 | 469.63 | 528.46 | 318.45 |
Change in Working Capital | 571.03 | 571.03 | -296.58 | 191.61 | 80.33 | -21.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.